[1] |
Furuta K, Guo Q, Hirsova P, et al. Emerging roles of liver sinusoidal endothelial cells in nonalcoholic steatohepatitis[J]. Biology, 2020, 9(11):395.
|
[2] |
Du W, Wang L. The crosstalk between liver sinusoidal endothelial cells and hepatic microenvironment in NASH related liver fibrosis[J]. Front Immunol, 2022, 13:936196.
|
[3] |
Nasiri-Ansari N, Androutsakos T, Flessa C M, et al. Endothelial cell dysfunction and nonalcoholic fatty liver disease (NAFLD): a concise review[J]. Cells, 2022, 11(16):2511.
|
[4] |
Wilkinson A L, Qurashi M, Shetty S. The role of sinusoidal endothelial cells in the axis of inflammation and cancer within the liver[J]. Front Physiol, 2020, 11:990.
|
[5] |
Mitten E K, Baffy G. Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease[J]. J Hepatol, 2022, 77(6):1642-1656.
|
[6] |
Zapotoczny B, Szafranska K, Kus E, et al. Tracking fenestrae dynamics in live murine liver sinusoidal endothelial cells[J]. Hepatology, 2019, 69(2):876-888.
|
[7] |
Wang X K, Peng Z G. Targeting liver sinusoidal endothelial cells: an attractive therapeutic strategy to control inflammation in nonalcoholic fatty liver disease[J]. Front Pharmacol, 2021, 12:655557.
|
[8] |
Poisson J, Lemoinne S, Boulanger C, et al. Liver sinusoidal endothelial cells: physiology and role in liver diseases[J]. J Hepatol, 2017, 66(1):212-227.
|
[9] |
Tateya S, Rizzo N O, Handa P, et al. Endothelial NO/cGMP/VASP signaling attenuates kupffer cell activation and hepatic insulin resistance induced by high-fat feeding[J]. Diabetes, 2011, 60(11):2792-2801.
|
[10] |
Yang F, Li H, Li Y, et al. Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis[J]. Int Immunopharmacol, 2021, 99:108051.
|
[11] |
Hammoutene A, Rautou P E. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease[J]. J Hepatol, 2019, 70(6):1278-1291.
|
[12] |
McMahan R H, Porsche C E, Edwards M G, et al. Free fatty acids differentially downregulate chemokines in liver sinusoidal endothelial cells: insights into non-alcoholic fatty liver disease[J]. Plos One, 2016, 11(7):e0159217.
|
[13] |
Neumann K, Rudolph C, Neumann C, et al. Liver sinusoidal endothelial cells induce immunosuppressive IL-10-producing Th1 cells via the Notch pathway[J]. Eur J Immunol, 2015, 45(7):2008-2016.
|
[14] |
Carambia A, Frenzel C, Bruns O T, et al. Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells[J]. J Hepatol, 2013, 58(1):112-118.
|
[15] |
Knolle P A, Uhrig A, Hegenbarth S, et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules[J]. Clin Exp Immunol, 2001, 114(3):427-433.
|
[16] |
Bhandari S, Larsen A K, McCourt P, et al. The scavenger function of liver sinusoidal endothelial cells in health and disease[J]. Front Physiol, 2021, 12:757469.
|
[17] |
Sayej W N, Knight Iii P R, Guo W A, et al. Advanced glycation end products induce obesity and hepatosteatosis in CD-1 wild-type mice[J]. BioMed Res Int, 2016, 2016:1-12.
|
[18] |
Gazi U, Martinez-Pomares L. Influence of the mannose receptor in host immune responses[J]. Immunobiology, 2009,214(7):554-561.
|
[19] |
Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis[J]. J Hepatol, 2018, 68(2):280-295.
|
[20] |
Ibrahim S H. Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications[J]. Am J Physiol-Gastrointest Liver Physiol, 2021, 321(1):G67-G74.
|
[21] |
Miyachi Y, Tsuchiya K, Komiya C, et al. Roles for cell-cell adhesion and contact in obesity-induced hepatic myeloid cell accumulation and glucose intolerance[J]. Cell Rep, 2017, 18(11):2766-2779.
|
[22] |
Marra F, Tacke F. Roles for chemokines in liver disease[J]. Gastroenterology, 2014, 147(3):577-594.e1.
|
[23] |
Sun X, Harris E N. New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease[J]. Am J Physiol-Cell Physiol, 2020, 318(6):C1200-C1213.
|
[24] |
Hilscher M B, Sehrawat T, Arab J P, et al. Mechanical stretch increases expression of cxcl1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension[J]. Gastroenterology, 2019, 157(1):193-209.e9.
|
[25] |
Shetty S, Lalor P F, Adams D H. Liver sinusoidal endothelial cells-gatekeepers of hepatic immunity[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(9):555-567.
|
[26] |
Patten D A, Wilson G K, Bailey D, et al. Human liver sinusoidal endothelial cells promote intracellular crawling of lymphocytes during recruitment: a new step in migration[J]. Hepatology, 2017, 65(1):294-309.
|
[27] |
Guo Q, Furuta K, Lucien F, et al. Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH[J]. J Hepatol, 2019, 71(6):1193-1205.
|
[28] |
Imhof B A, Aurrand-Lions M. Angiogenesis and inflammation face off[J]. Nat Med, 2006, 12(2):171-172.
|
[29] |
Lefere S, Van De Velde F, Hoorens A, et al. Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease[J]. Hepatology, 2019, 69(3):1087-1104.
|
[30] |
Coulon S, Heindryckx F, Geerts A, et al. Angiogenesis in chronic liver disease and its complications: angiogenesis in CLD[J]. Liver Int, 2011, 31(2):146-162.
|
[31] |
Miura K, Yang L, Van Rooijen N, et al. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2[J]. Am J Physiol-Gastrointest Liver Physiol, 2012, 302(11):G1310-G1321.
|
[32] |
Iwakiri Y. Nitric oxide in liver fibrosis: the role of inducible nitric oxide synthase[J]. Clin Mol Hepatol, 2015, 21(4):319.
|
[33] |
Leung T M, Fung M L, Liong E C, et al. Role of nitric oxide in the regulation of fibrogenic factors in experimental liver fibrosis in mice[J]. Histol Histopathol, 2010, (26):201-211.
|
[34] |
Ruart M, Chavarria L, Campreciós G, et al. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury[J]. J Hepatol, 2019, 70(3):458-469.
|
[35] |
Hammoutene A, Biquard L, Lasselin J, et al. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis[J]. J Hepatol, 2020, 72(3):528-538.
|
[36] |
Parthasarathy G, Hirsova P, Kostallari E, et al. Extracellular vesicles in hepatobiliary health and disease[J]. Compr Physiol, 2023, 13(3): 4631-4658.
|
[37] |
Garcia-Martinez I, Santoro N, Chen Y, et al. Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9[J]. J Clin Invest, 2016, 126(3):859-864.
|
[38] |
Kakazu E, Mauer A S, Yin M, et al. Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner[J]. J Lipid Res, 2016, 57(2):233-245.
|
[39] |
Ibrahim S H, Hirsova P, Tomita K, et al. Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes[J]. Hepatology, 2016, 63(3):731-744.
|